News

What is new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

New key publication: large scale study in metabolic syndrome

Groningen, the Netherlands. June 13, 2017.

Recently a new scientific paper about the AGE Reader was published. It concerns an analysis of 78.671 non-diabetics subjects of the LifeLines study, a longitudinal cohort study with 167.000 participants. The aim of this study was to examine the association between the AGE Reader measurement and the presence of the metabolic syndrome as well as its individual components in a general population.

In this publication the authors conclude that the AGE Reader measurement was significantly associated with the presence of metabolic syndrome and some of its individual components. Please click here for the full-text version of this paper.

What is the added value of this validation paper for the AGE Reader? 

  • This study provides clinical validation in a very large study group of almost 80.000 subjects.
  • This study is performed in general population and not in a specific patient group.
  • This study provides new data for a broad application as a non-invasive screening tool to detect individuals at high risk for both cardiovascular disease and type 2 diabetes.

Share this link on:

Latest news items

  1. New key publication: large scale study in metabolic syndrome 2017
  2. Diagnoptics appoints DiosPharma as the new Korean distributor 2016
  3. Visit Diagnoptics at the EASD congress 2016 in Munich 2016
  4. Selista appointed as new Japanese distributor for the AGE Reader mu 2016
  5. Diagnoptics bei dem DDG Kongress in Berlin 2016
  6. Diagnoptics receives Chinese market approval for AGE Reader SU 2016
  7. New patent granted to Diagnoptics in Japan and EU. 2016
  8. Diagnoptics receives Japanese market approval for AGE Reader mu. 2015
  9. Diagnoptics nominated for Deloitte Technology Fast50 2015
  10. Scientific review emphasises need for AGE measurements and interventions 2015
  11. Dutch government supports Diagnoptics and CTMM research project 2015
  12. Key publication: AGE Reader predicts amputation 2015
  13. New AGE Reader video available: quick start guide and user instructions. 2015
  14. Diagnoptics appoints Forel Medical as new Polish distributor 2015
  15. Diagnoptics appoints Microcaya as new Spanish distributor 2015
  16. Diagnoptics appoints ANL Produkter AB as new Swedish distributor 2015
  17. Exciting video: AGE Reader clinical case study 2014
  18. Review about AGE Reader in assessing CV risk and risk of diabetes 2014
  19. Excellent presentation about Advanced Glycation Endproducts (Dutch) 2014
  20. Editorial confirms added value of AGE Reader in atherosclerosis 2014
  21. Breakthrough publication: AGE Reader in atherosclerosis 2014
  22. German review AGE Reader 2014
  23. Upcoming Conferences 2014
  24. DiagnOptics moved to another location. 2014
  25. AGE Reader on national television 2013
  26. A.J. Smit appointed professor at the UMCG 2013
  27. Visit DiagnOptics at the EASD 2013 2013
  28. Clinical validation Diab-spot published 2013
  29. DiagnOptics receives CE mark approval for AGE Reader mu 2013
  30. DiagnOptics to show new product at international diabetes meetings in 2013 2012
  31. AGE Reader presented at German national diabetes conference in Berlin. 2012
  32. Successful introduction of the AGE Reader mu 2012
  33. Important role of AGE Reader shown in recent international publications 2012
  34. DiagnOptics present at the EASD 2012 in Berlin 2012
  35. DiagnOptics receives Health Canada approval for Diab-spot 2012
  36. DiagnOptics and PATH partner on project on diabetes screening in India 2012
  37. DiagnOptics receives CE mark approval for Diab-spot. 2011
  38. DiagnOptics receives Health Canada approval for the AGE Reader. 2011
  39. New product for diabetes detection, Diab-spot, introduced in Madrid. 2011
  40. DiagnOptics receives ISO 13485 certification. 2010
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors.

Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

Downloads

Downloads about the AGE Reader and Diab-spot

About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.